MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-KR-03-0016061
Nagarika Generics India Private Limited
Nagarika Generics India Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹49.51 Lakh
▲ 39% YoY
Net profit · FY 2024
₹1.15 Lakh
Net margin 2.3%
EBITDA · FY 2024
₹4.64 Lakh
EBITDA margin 9.4%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.24 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
3
Provident fund records
Directors on board
7
As per MCA filings
About Nagarika Generics India Private Limited
Data last updated:
Nagarika Generics India Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2020PTC134808. Its GSTIN is 29AAGCN9723L1ZS (Karnataka).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.24 Cr. It is led by directors including Muralidhara Bindumalyam Ashwini and Bindumalyam Aishwarya Muralidhar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.213 80 Feet Road 4th Main Road Jp Nagar 2nd Phase, Bangalore, Karnataka, India – 560078.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.51 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Lakh (net margin 2.3%) and EBITDA of ₹4.64 Lakh (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years.
The company has about 3 employees on its provident fund (EPFO) records.
Nagarika Generics India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0016061).
Company details
CIN U51909KA2020PTC134808
Registration Number 134808
Incorporation Date 10 June 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0016061
Key People
Muralidhara Bindumalyam Ashwini Director Bindumalyam Aishwarya Muralidhar Director Kishore Kumar Rajagopal Additional Director Recognitions & Rankings of Nagarika Generics India
Contact details
Nagarika Generics India Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo.213 80 Feet Road 4th Main Road Jp Nagar 2nd Phase, Bangalore, Karnataka, India – 560078
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nagarika Generics India Private Limited, buy the company report.
Comprehensive company report
Nagarika Generics India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nagarika Generics India is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nagarika Generics India Private Limited, buy the company report.
Financials of Nagarika Generics India Private Limited
FY 2025 filings availableNagarika Generics India Private Limited reported revenue of ₹49.51 Lakh (up 39% YoY) for FY 2024.
Revenue · FY 2024
₹49.51 Lakh ▲ 39%
Net profit · FY 2024
₹1.15 Lakh margin 2.3%
EBITDA · FY 2024
₹4.64 Lakh margin 9.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 73%
EBITDA CAGR growth
1 year
▲ 114%
3 years · compounded
▲ 27%
Revenue has grown at a compounded annual rate (CAGR) of 73% over three years, including 39% growth in the latest year. EBITDA rose 114% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹4.64 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.15 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.4% | |||
| Net Profit Margin | 2.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nagarika Generics India Private Limited, buy the company report.
Board of directors of Nagarika Generics India Private Limited
Nagarika Generics India has 7 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muralidhara Bindumalyam Ashwini | Director | 10 Jun 2020 | 6 Years 4 Months | Current |
| Bindumalyam Aishwarya Muralidhar | Director | 10 Jun 2020 | 6 Years 4 Months | Current |
| Kishore Kumar Rajagopal Also directs: Vyjayanth Projects LLP, Acquity Labs Private Limited, Kids Clinic India Limited and 1 more | Additional Director | 19 Jun 2020 | 6 Years 4 Months | Current |
| Anil Laxmichand Also directs: A K R Engg and Projects LLP, Sukran and Associates LLP, Sundar Sons India Private Limited and 1 more | Additional Director | 19 Jun 2020 | 6 Years 4 Months | Current |
| Muntimadagu Rathnam Manjunatha | Director | 10 Jun 2020 | 6 Years 4 Months | Current |
| Muralidhara Gopalakrishnaiah Bindumalyam Also directs: Srinidhi Trinity Nest LLP, Srinidhi Trinity Infra LLP, Trinity Medicity India Private Limited and 3 more | Director | 10 Jun 2020 | 6 Years 4 Months | Current |
Showing 6 of 7 current directors. View all directors
Legal cases
No court or tribunal cases involving Nagarika Generics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nagarika Generics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nagarika Generics India Private Limited has a workforce of 3 employees on its EPFO records as of Apr 11, 2024, across 1 active EPFO establishment.
Employee count
3
Active EPFO establishments
1
Employee growth
-40%
GST
Nagarika Generics India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAGCN9723L1ZS | Karnataka | Active | 19 Jun 2020 |
To see the full GST registrations and return filing status of Nagarika Generics India Private Limited, buy the company report.
Recent activity
Nagarika Generics India Private Limited has 7 board changes on record since 2020: 7 appointments. The latest: Anil Laxmichand was appointed as Additional Director on 19 Jun 2020.
AGM
Nagarika Generics India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nagarika Generics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Anil Laxmichand was appointed as Additional Director.
Appointed
Kishore Kumar Rajagopal was appointed as Additional Director.
Appointed
Anuradha Muralidhara Bindumalyam was appointed as Director.
Appointed
Bindumalyam Aishwarya Muralidhar was appointed as Director.
Appointed
Muntimadagu Rathnam Manjunatha was appointed as Director.
Appointed
Muralidhara Bindumalyam Ashwini was appointed as Director.
Appointed
Muralidhara Gopalakrishnaiah Bindumalyam was appointed as Director.
Incorporation
10 Jun 2020
Nagarika Generics India Private Limited was registered on 10 Jun 2020 with Roc Bangalore & aged 6 years 4 months as per MCA records.
Frequently asked questions
Nagarika Generics India is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 June 2020 (6+ years old) and is registered under CIN U51909KA2020PTC134808.
Nagarika Generics India has 7 current directors:
- Muralidhara Bindumalyam Ashwini - Director
- Bindumalyam Aishwarya Muralidhar - Director
- Kishore Kumar Rajagopal - Additional Director
- Anil Laxmichand - Additional Director
- Muntimadagu Rathnam Manjunatha - Director
- Muralidhara Gopalakrishnaiah Bindumalyam - Director
- Anuradha Muralidhara Bindumalyam - Director
The latest financial statements of Nagarika Generics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Nagarika Generics India is 29AAGCN9723L1ZS, registered in Karnataka.
The CIN (Corporate Identification Number) of Nagarika Generics India is U51909KA2020PTC134808. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nagarika Generics India was incorporated on 10 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
Anil Laxmichand was appointed as Additional Director on 19 Jun 2020. Kishore Kumar Rajagopal was appointed as Additional Director on 19 Jun 2020. Anuradha Muralidhara Bindumalyam was appointed as Director on 10 Jun 2020. Nagarika Generics India has 7 board changes on record in total.
Yes, Nagarika Generics India is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0016061).
The registered office of Nagarika Generics India is at No.213 80 Feet Road 4th Main Road Jp Nagar 2nd Phase, Bangalore, Karnataka, India – 560078.
Nagarika Generics India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.